GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,036 Cr | ₹928 Cr | ₹590 Cr | ₹611 Cr | ₹1,695 Cr |
What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹1,036 Cr |
| Mar2025 | ₹928 Cr |
| Mar2024 | ₹590 Cr |
| Mar2023 | ₹611 Cr |
| Mar2022 | ₹1,695 Cr |
How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,036 Cr | 11.69 | |
| Mar2025 | ₹928 Cr | 57.23 | |
| Mar2024 | ₹590 Cr | -3.39 | |
| Mar2023 | ₹611 Cr | -63.97 | |
| Mar2022 | ₹1,695 Cr | - | |
Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹49,915.4 Cr | -1.1% | 12.7% | 9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.1% |
12.7% |
9.5% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses